Business
Quantum eMotion Announces Issuance of Q3 Financial Reports and Clarification Regarding Previously Disclosed Stock Options Grants
Montreal, Quebec--(Newsfile Corp. - November 26, 2025) - Quantum eMotion Corp.  (TSXV: QNC)...
About this update from Quantum Emotion Corp.
[{"type":"text","content":"Quantum eMotion Announces Issuance of Q3 Financial Reports and Clarification Regarding Previously Disclosed Stock Options GrantsMontreal, Quebec--(Newsfile Corp. - November 26, 2025) - Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) (FSE: 34Q0) (\"QeM\"), a leader in quantum-safe cybersecurity innovation, has released its Q3 Financial Statements accompanied by its Q3 MD&A. Following the successful LIFE offerings that closed in the first half of 2025 that generated net proceeds of $20.3 million to QeM; the company is pleased to report that 15.3 million warrants have been exercised during the course of the nine-month period ending September 30, 2025, resulting in additional cash proceeds of $6.3 million and a cash balance at the end of the period of $24.7 million. This positions the company favorably to invest in opportunities, increase our R&D efforts as well as continue the transition to commercialisation which started earlier this year and which includes enhancing our visibility and presence in the USA with the opening of a subsidiary. The Company's Management's Discussion and Analysis and Consolidated Financial Statements for the three and nine months ended September 30, 2025, are available on the company's website and on Sedar+.Clarification regarding Previously Disclosed Stock Option GrantsOn March 21, 2025, we reported that 3,920,000 stock options had been granted to officers and employees of the Corporation, whereas the correct number is 3,820,000. There were also discrepancies in news releases of the Corporation dated February 19, 2021, December 23, 2020 and December 18, 2020, regarding the term of an aggregate of 4,050,000 stock options granted to senior officers and a director of the Corporation. The news releases inaccurately stated that these stock options had a three-year term. In fact:2,500,000 stock options with an exercise price of $0.185 (previously reported as $0.14), as announced on February 19, 2021, granted to the Chief Executive Officer of the Corporation, have a ten-year term and are valid until February 2, 2031;500,000 stock options with an exercise price of $0.185 (previously reported as $0.14), as announced on February 19, 2021, and granted to a director, have a seven-year term and are valid until January 27, 2028;750,000 stock options with an exercise price of $0.065, as announced on ...